Eversource Energy (ES) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
6 Nov, 2025Executive summary
Q3 2025 net income was $367.5M ($0.99/share), up from a loss of $118.1M in Q3 2024, with non-GAAP recurring earnings at $442.5M ($1.19/share); nine-month net income was $1.27B ($3.44/share), driven by higher regulated segment earnings and lower offshore wind losses.
Strategic focus on a fully regulated business model, $24.2B capital plan through 2029, and leadership in the New England energy transition.
Substantial progress on Revolution Wind and AMI deployment, with onshore substation nearly complete and project de-risked.
Regulatory clarity and progress in Connecticut, Massachusetts, and New Hampshire, including key rate cases and the pending Aquarion Water sale.
Continued investment in grid infrastructure and robust load growth from electrification and economic expansion.
Financial highlights
Q3 2025 GAAP EPS was $0.99, up from $-0.33 in Q3 2024; non-GAAP recurring EPS was $1.19, up from $1.13; nine-month non-GAAP EPS was $3.64, up from $3.56.
Q3 2025 operating revenues were $3.22B, up $157M year-over-year; YTD revenues were $10.18B, up $1.25B.
Operating cash flows increased to $3.20B YTD 2025, up from $1.52B YTD 2024.
Offshore wind contingent liability increased by $284M in Q3 2025, resulting in a $75M after-tax charge.
Outlook and guidance
2025 non-GAAP recurring EPS guidance narrowed to $4.72–$4.80, with a reaffirmed 5–7% long-term EPS growth rate off a 2024 non-GAAP base of $4.57.
Five-year capital plan of $24.2B through 2029, with $3.3B executed YTD and $1.5–$2B in additional investment opportunities identified.
Rate base projected to grow at an 8.0% CAGR from $26.4B in 2023 to $41.9B in 2029.
Latest events from Eversource Energy
- 2025 EPS reached $4.76; 2026 guidance is $4.80–$4.95 with $26.5B capex and 5–7% growth outlook.ES
Q4 202513 Feb 2026 - Q2 2024 earnings surged on wind asset sales and strong transmission, with EPS guidance reaffirmed.ES
Q2 20242 Feb 2026 - Q3 loss from offshore wind exit, but core earnings, $23.7B capex, and clean energy focus up.ES
Q3 202416 Jan 2026 - 5.3% EPS growth, $2.4B Aquarion sale, and $24.2B capex plan with 2025 EPS guidance of $4.67–$4.82.ES
Q4 20248 Jan 2026 - Q1 2025 net income rose to $550.8M, with EPS guidance and long-term growth reaffirmed.ES
Q1 202525 Dec 2025 - Exceeded non-GAAP EPS targets, advanced clean energy, and strengthened governance and compensation alignment.ES
Proxy Filing1 Dec 2025 - 2024 saw strong reliability, clean energy progress, and major governance and compensation votes ahead.ES
Proxy Filing1 Dec 2025 - Definitive proxy filed for annual meeting with standard voting items and no fee required.ES
Proxy Filing1 Dec 2025 - Five major proposals, including governance changes and executive pay, up for vote at 2025 meeting.ES
Proxy Filing1 Dec 2025